ARTICLE | Company News
TNI BioTech cancer, inflammation, infectious news
May 12, 2014 7:00 AM UTC
TNI will spin out its wholly owned subsidiary Cytocom Inc. to operate TNI's drug development business. The newco will initially focus on developing TNI's immunotherapy products IRT-103, which is low-d...